Fermenta Biotec. (506414)
STALWARTFairStock Score: 24/100 — RISKY
Score breakdown: P/E: 3/3 · ROCE: 1/2 · Growth: 0/2 · Dividend: 0/1
Key Financials
| Current Price | ₹238.5 |
| Market Cap | ₹714.78 Cr |
| P/E Ratio | 10.82 |
| ROCE | 22.97% |
| ROE | 22.87% |
| Dividend Yield | 0.77% |
| Profit Growth | -61.56% |
| Debt/Equity | — |
| Sales Growth | -12.21% |
| 52-Week Range | ₹256.4 — ₹399 |
| Sector | Pharmaceuticals & Biotechnology |
| Book Value | ₹107.02 |
Fermenta Biotec. trades with a P/E ratio of 10.82, ROCE of 22.97%, ROE of 22.87%, profit growth of -61.56%. The FairStock Score of 24/100 flags concerns across multiple fundamental dimensions that investors should examine carefully.
Data from BSE/NSE filings. AI analysis is for educational purposes only — not investment advice. Scoring methodology · Disclaimer